-- 摩根士丹利周一发布的一份报告指出，StubHub (STUB) 在客户获取方面的投入预计将在 2026 年放缓，这将支撑其全年调整后息税折旧摊销前利润 (EBITDA) 同比增长率达到约 70% 至 80% 的预期。 摩根士丹利表示，随着公司营销力度的放缓，StubHub 可以更稳步地提升市场份额和利润率，从而在基本假设下，支撑其 2026 年至 2029 年三年营收和 EBITDA 复合年增长率分别达到 7% 和 13%。 摩根士丹利指出，该公司目前占据北美二手票市场 45% 的份额，并补充说，由于多家竞争对手可能限制其利润率增长并压低成交率，因此，摩根士丹利仍然认为二手票市场竞争激烈，并对 2026 年以后的增长持更为谨慎的态度。 摩根士丹利表示，受国际足联世界杯的推动，其对2026年StubHub的预期和市场普遍预期均有显著上行空间，并认为该赛事有望为今年的增长贡献约4%。 该行首次对StubHub进行评级，给予“中性”评级，目标价为8.25美元。
Price: $7.24, Change: $+0.09, Percent Change: +1.26%
Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml
Celestica (CLS) reported Q1 adjusted earnings late Monday of $2.16 per diluted share, up from $1.20 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended March 31 was $4.05 billion, up from $2.65 billion a year earlier.Analysts surveyed by FactSet expected $4.04 billion.For Q2, the company expects adjusted EPS of $2.14 to $2.34 on revenue of $4.15 billion to $4.45 billion. Analysts expect EPS of $2.13 on revenue of $4.17 billion.The company now expects 2026 adjusted EPS of $10.15 on revenue of $19 billion, revised from $8.75 and $17 billion, respectively, expected earlier. Analysts expect EPS of $8.93 on revenue of $17.34 billion.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target price of $550, valuing AMP shares at 12.5x our 2026 adjusted EPS estimate of $43.84 (raised by $1.34) and at 11.7x our 2027 EPS estimate of $46.90 (raised by $0.70). This compares to the three-year average forward multiple of 12x and peer average of 15.5x. AMP posted Q1 2026 adjusted operating EPS of $11.26 vs. $9.50, a 19% rise that topped our $10.12 estimate and $10.21 consensus view. Revenue growth of 11% exceeded our forecast and our 6%-10% growth forecast for 2026, while pretax adjusted operating margins expanded 130 bps to 28% on revenue gains and cost containment efforts. We now see revenue growth of 7% to 12% in 2026 and 2027. AMP also continued its substantial capital return program, returning $936M to shareholders in Q1 (70% of adjusted operating earnings) and $3.4B in 2025 (88% of earnings). Currently trading at 10.9x our 2026 EPS estimate, and with some decent revenue and earnings momentum, we view the shares as undervalued versus peer and historical averages.